Welcome to the international HTA database

Showing [23537 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Group therapy for adults with axis II disorders: a review of clinical effectiveness
2009	National Institute for Health and Care Excellence (NICE)	Topotecan for the treatment of recurrent and stage IVB cervical cancer. NICE technology appraisal guidance 183
2009	Penn Medicine Center for Evidence-based Practice (CEP)	Allen test for predicting complications from arterial cannulation
2009	VA Technology Assessment Program (VATAP)	Systematic reviews for podiatry
2009	Institute for Clinical Evaluative Sciences (ICES)	Blood glucose test strip use: patterns, costs and potential cost reduction associated with reduced testing
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Group therapy for anxiety: a review of the clinical effectiveness
2009	The Netherlands Organisation for Health Research and Development (ZonMw)	[Cost effectiveness of scalp cooling in the prevention of chemotherapy-induced hair loss]
2009	Agency for Healthcare Research and Quality (AHRQ)	Use of Bayesian techniques in randomized clinical trials: a CMS case study
2009	German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI)	[Computerized physician order entry - effectiveness and efficiency of electronic medication ordering with decision support systems]
2009	Penn Medicine Center for Evidence-based Practice (CEP)	IV injection sites for post-mastectomy patients
2009	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Amotosalen (Intercept) for the inactivation of pathogens for transfusion therapy]
2009	VA Technology Assessment Program (VATAP)	Systematic reviews for amyotrophic lateral sclerosis
2009	Institute for Clinical Evaluative Sciences (ICES)	What does it take to make a healthy province? A benchmark study of jurisdictions in Canada and around the world with the highest levels of health and the best health behaviours
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Group therapy in the treatment of schizophrenia: a review of the clinical effectiveness
2009	National Institute for Health and Care Excellence (NICE)	Sunitinib for the treatment of gastrointestinal stromal tumours. NICE technology appraisal guidance 179
2009	Medical Advisory Secretariat (MAS)	Screening methods for early detection of colorectal cancers and polyps: summary of evidence-based analyses
2009	Penn Medicine Center for Evidence-based Practice (CEP)	IV placement in chronic kidney disease patients
2009	Blue Cross Blue Shield Association (BCBS)	CT colonography (virtual colonoscopy) for colon cancer screening
2009	The Swedish Council on Health Technology Assessment (SBU)	[How can drug consumption among the elderly be improved?]
2009	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Angiographic profile of patients undergoing drug eluting stent implantation in Spain. Variability of off-label indications]
2009	VA Technology Assessment Program (VATAP)	Systematic reviews for nurse-led primary care
2009	Institute for Clinical Evaluative Sciences (ICES)	Registry of the Canadian Stroke Network. Report on the 2004/05 Ontario Stroke Audit
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Pathogen reduction technologies for blood products: a review of the clinical effectiveness, cost-effectiveness, and guidelines
2009	National Institute for Health and Care Excellence (NICE)	Pemetrexed for the first-line treatment of non-small-cell lung cancer. NICE technology appraisal guidance 181
2009	German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI)	[Medical and health economic assessment of radiosurgery for the treatment of brain metastasis]
2009	Penn Medicine Center for Evidence-based Practice (CEP)	Prevention of ventilator-associated pneumonia
2009	Blue Cross Blue Shield Association (BCBS)	Special report: critical appraisal of CT colonography cost-effectiveness analyses
2009	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Artificial liver support systems]
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Lithotripsy for kidney stones or gallstones: a review of the clinical effectiveness, cost-effectiveness, and guidelines
2009	National Institute for Health and Care Excellence (NICE)	Alitretinoin for the treatment of severe chronic hand eczema. NICE technology appraisal guidance 177
2009	Penn Medicine Center for Evidence-based Practice (CEP)	Prevention and management of delirium
2009	HAYES, Inc.	Endoscopic retrograde cholangiopancreatography for the treatment of benign and malignant diseases of the pancreas and biliary tree
2009	Blue Cross Blue Shield Association (BCBS)	Artificial intervertebral disc arthroplasty for treatment of degenerative disc disease of the cervical spine
2009	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[AUDIT ONCOrisk: Quality of the information in the study about digestive oncological surgery results]
2009	VA Technology Assessment Program (VATAP)	Regionalization of surgical services
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Addendum to the Canadian Agency for Drugs and Technologies in Health guidelines for the economic evaluation of health technologies: specific guidance for oncology products
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Aortoiliofemoral arteriogram-guided peripheral vascular stenting: a review of the clinical and cost-effectiveness
2009	National Institute for Health and Care Excellence (NICE)	Bevacizumab (first-line), sorafenib (first- and second-line), sunitinib (second-line) and temsirolimus (first-line) for the treatment of advanced and/or metastatic renal cell carcinoma. NICE technology appraisal guidance 178
2009	Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS)	[Reuse of single use medical devices]
2009	Agency for Healthcare Research and Quality (AHRQ)	Horizon Scan: to what extent do changes in third-party payment affect clinical trials and the evidence base
2009	Institute for Clinical Effectiveness and Health Policy (IECS)	Prostacyclins (epoprostenol, iloprost, treprostinil and beraprost) for the management of primary pulmonary hypertension and pulmonary hypertension in collagen vascular disease
2009	HAYES, Inc.	Endovenous laser therapy for varicose veins due to great saphenous vein reflux
2009	Blue Cross Blue Shield Association (BCBS)	Off-label use of bevacizumab: advanced adenocarcinoma of the pancreas
2009	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Comparison of the effectiveness of slow-release dosage forms (depot) versus oral dosage forms of antipsychotics (typical and atypical), marketed in Catalonia, in patients with a diagnosis of schizophrenia]
2009	HAYES, Inc.	Nanoparticle-based cancer therapies: Albumin-bound paclitaxel
2009	VA Technology Assessment Program (VATAP)	Simulation training
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Radioimmunotherapies for non-hodgkin lymphoma: systematic review of clinical effectiveness, cost-effectiveness, and guidelines
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Endovascular coiling versus surgical clipping: a review of the clinical and cost-effectiveness
2009	National Institute for Health and Care Excellence (NICE)	Tenofovir disoproxil for the treatment of chronic hepatitis B. NICE technology appraisal guidance 173
2009	The Netherlands Organisation for Health Research and Development (ZonMw)	[Effects and costs of a combined screening and treatment program for elderly (aged 75 years and over) with depressive symptoms in general practice]
2009	German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI)	[Behavioural and skill-based early interventions in children with autism spectrum disorders]
2009	HAYES, Inc.	Endovenous laser therapy for varicose veins due to small saphenous vein reflux
2009	Blue Cross Blue Shield Association (BCBS)	Transcranial magnetic stimulation for depression
2009	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Defibrillators in public places]
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Recombinant activated Factor VII in treatment of hemorrhage unrelated to hemophilia: a systematic review and economic evaluation
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Carotid artery stenting versus carotid endarterectomy: a review of the clinical and cost-effectiveness
2009	National Institute for Health and Care Excellence (NICE)	Rituximab for the first-line treatment of chronic lymphocytic leukaemia. NICE technology appraisal guidance 174
2009	German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI)	[Human papillomavirus (HPV) vaccination for the prevention of HPV 16/18 induced cervical cancer and its precursors]
2009	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Development of a shared knowledge system for network assessment of technological innovation in medicine]
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Drugs for pulmonary arterial hypertension: a systematic review of the clinical-effectiveness of combination therapy
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Elective endovascular abdominal aortic aneurism repair versus open surgery: a review of the clinical and cost-effectiveness
2009	National Institute for Health and Care Excellence (NICE)	Rivaroxaban for the prevention of venous thromboembolism after total hip or total knee replacement in adults. NICE technology appraisal guidance 170
2009	The Netherlands Organisation for Health Research and Development (ZonMw)	[Cost-effectiveness of the Australian medical sheepskin for the prevention of pressure ulcers in somatic nursing home clients]
2009	German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI)	[Effectiveness and cost-efficiency of phosphate binders in hemodialysis]
2009	Technology Assessment Unit of the McGill University Health Centre (MUHC)	[The use of carmustine implants (Gliadel wafers) in patients with malignant glioma]
2009	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Eculizumab for the treatment of paroxysmal nocturnal haemoglobinuria]
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Octaplas compared with fresh frozen plasma to reduce the risk of transmitting lipid-enveloped viruses: an economic analysis and budget impact analysis
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Sterilization of foot care instruments: a review of the guidelines
2009	National Institute for Health and Care Excellence (NICE)	Sunitinib for the first-line treatment of advanced and/or metastatic renal cell carcinoma. NICE technology appraisal guidance 169
2009	German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI)	[Assessments tools for risk prediction of cardiovascular diseases]
2009	Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS)	[Curative treatment for esophageal cancer: systematic review of neoadjuvant therapy and chemoradiotherapy alone: summary]
2009	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Effectiveness of the filum terminale section for the treatment of Chiari I malformation]
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Intravenous immunoglobulin for chronic inflammatory demyelinating polyneuropathy: Clinical- and cost-effectiveness analyses
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Universal, community-based developmental screening tools for children 6 years and younger: a review of clinical effectiveness
2009	National Institute for Health and Care Excellence (NICE)	Amantadine, oseltamivir and zanamivir for the treatment of influenza. NICE technology appraisal guidance 168
2009	Health Information and Quality Authority (HIQA)	Health technology assessment (HTA) of a population-based colorectal cancer screening programme in Ireland
2009	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Hadrontherapy in the treatment of cancer]
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Resin-bonded fixed bridges and conventional fixed bridges: a review of the advantages and disadvantages and indications
2009	National Institute for Health and Care Excellence (NICE)	Machine perfusion systems and cold static storage of kidneys from deceased donors. NICE technology appraisal guidance 165
2009	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Chemo-nucleolysis and intradiscal electrotherapy. Systematic Review
2009	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Health and health services use in immigrant and native population in Spain]
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Foot care for patients with peripheral vascular disease: a review of the guidelines
2009	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Percutaneous nucleotomy and percutaneous laser disk decompression. Systematic Review
2009	NIHR Horizon Scanning Centre (NIHR HSC)	Spiral Laminar Flow bypass graft for peripheral arterial disease
2009	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Impact of clinical and health services research in advancing knowledge. Applied study to the CAHTA research calls]
2009	Danish Centre for Evaluation and Health Technology Assessment (DACEHTA)	[Home visits to patients with severe COPD - a health technology assessment]
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Urine based testing for gonorrhea and chlamydia: a review of diagnostic accuracy, cost-effectiveness, and compliance
2009	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Injection therapies and radiofrequency for the treatment of chronic back pain. Systematic Review
2009	NIHR Horizon Scanning Centre (NIHR HSC)	Pregabalin (Lyrica) for partial onset epilepsy - monotherapy
2009	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Implementation and development of a treatment programme for peritoneal carcinomatosis in Catalonia. Indications and clinical results using Sugarbaker's technique]
2009	Danish Centre for Evaluation and Health Technology Assessment (DACEHTA)	[Follow-Up for gynecological cancer]
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Naltrexone for the treatment of alcohol dependence in individuals with co- dependencies: a review of the clinical effectiveness
2009	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Intraoperative radiotherapy for primary breast cancer. Systematic Review
2009	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Classification of disease severity for neuro- and trauma rehabilitation. Part 2: international experiences with quality / performance assessments and reimbursement
2009	NIHR Horizon Scanning Centre (NIHR HSC)	Dasatinib (Sprycel) for chronic myeloid leukaemia - first line
2009	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Influence of an existing health care plan aimed at managing ST-elevation myocardial infarction on the waiting time until re-perfusion, and types of re-perfusion. Pilot study]
2009	Committee for New Health Technology Assessment (CNHTA)	[ADAMTS 13 Activity]
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Naltrexone in combination with acamprosate for the treatment of alcohol dependence: a review of the clinical and cost-effectiveness
2009	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Drug coated balloon catheter. Systematic Review
2009	NIHR Horizon Scanning Centre (NIHR HSC)	Carisbamate for partial onset epilepsy